# Lidocaine VS Hemodynamic, Metabolic and Hormonal Response

> **NCT05238506** · PHASE4 · COMPLETED · sponsor: **Medical University of Warsaw** · enrollment: 132 (actual)

## Conditions studied

- Hemodynamic Response
- Acute Appendicitis
- Complication of Treatment
- Opioid Consumption
- Pneumoperitoneum

## Interventions

- **DRUG:** Intravenous lidocaine
- **DRUG:** Normal saline infusion

## Key facts

- **NCT ID:** NCT05238506
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-12
- **Primary completion:** 2023-08-08
- **Final completion:** 2023-08-08
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2023-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05238506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05238506, "Lidocaine VS Hemodynamic, Metabolic and Hormonal Response". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05238506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*